ABSTRACT
Idiopathic rapid eye movement sleep behaviour disorder is an important risk factor in the development of Parkinson's disease. Numerous potential predictive markers of Parkinson's disease may present before motor symptoms emerge, but testing of these markers in rapid eye movement sleep behaviour disorder has been performed only in small studies. There has been no comparison of markers between patients with idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease, and between men and women. We evaluated an array of potential Parkinson's disease predictive markers in 159 patients; including 68 with idiopathic rapid eye movement sleep behaviour disorder, 36 controls, 34 Parkinson's patients with rapid eye movement sleep behaviour disorder and 21 Parkinson's patients without rapid eye movement sleep behaviour disorder. Compared with controls, patients with idiopathic rapid eye movement sleep behaviour disorder demonstrated substantial olfactory loss (P < 0.001). Olfaction was more impaired in Parkinson's disease than idiopathic rapid eye movement sleep behaviour disorder and did not differ between Parkinson's patients with, or without, rapid eye movement sleep behaviour disorder. Numerous measures of motor function including the Unified Parkinson Disease Rating Scale alternate tap, Purdue Peg Board and Timed 'Up and Go' were impaired in idiopathic rapid eye movement sleep behaviour disorder compared with controls (P < 0.01). All of these motor measures were worse with Parkinson's disease than with idiopathic rapid eye movement sleep behaviour disorder, regardless of rapid eye movement sleep behaviour disorder status. Autonomic symptoms and systolic blood pressure drop were impaired in patients with idiopathic rapid eye movement sleep behaviour disorder compared with controls (P = 0.003). Orthostatic abnormalities in Parkinson's disease were found in the group with rapid eye movement sleep behaviour disorder (P < 0.001). However, Parkinson's patients without rapid eye movement sleep behaviour disorder were not different than controls and had less impairment than those with idiopathic rapid eye movement sleep behaviour disorder (P = 0.004) and Parkinson's patients with rapid eye movement sleep behaviour disorder (P < 0.001). Colour vision was impaired in idiopathic rapid eye movement sleep behaviour disorder compared with controls (P < 0.001). However, only Parkinson's patients with rapid eye movement sleep behaviour disorder had abnormalities significantly different than controls (P < 0.001), and there were significant differences between Parkinson's patients with or without rapid eye movement sleep behaviour disorder (P < 0.04). Idiopathic rapid eye movement sleep behaviour disorder patients had slightly increased harm avoidance scores on personality testing (P = 0.04). Other than slightly better performances among women in the Purdue Peg Board, there was no difference in any measure between men and women, suggesting similar pathogenic processes underlying rapid eye movement sleep behaviour disorder. Patients with idiopathic rapid eye movement sleep behaviour disorder demonstrate abnormalities in numerous potential markers of neurodegenerative disease--these markers are heterogeneous, generally correlate with each other and occur equally in men and women. Although these abnormalities are usually intermediate between control values and Parkinson's patients, autonomic dysfunction and colour vision appear to be more linked to rapid eye movement sleep behaviour disorder status than Parkinson's disease, suggesting a unique pathophysiology of these abnormalities.
Subject(s)
Brain/physiopathology , Nerve Degeneration/diagnosis , Parkinson Disease/diagnosis , REM Sleep Behavior Disorder/diagnosis , Adult , Aged , Aged, 80 and over , Autonomic Nervous System Diseases/diagnosis , Autonomic Nervous System Diseases/etiology , Autonomic Nervous System Diseases/physiopathology , Biomarkers , Diagnosis, Differential , Female , Humans , Hypotension/diagnosis , Hypotension/etiology , Hypotension/physiopathology , Male , Middle Aged , Nerve Degeneration/etiology , Nerve Degeneration/physiopathology , Neurologic Examination , Neuropsychological Tests , Olfaction Disorders/diagnosis , Olfaction Disorders/etiology , Olfaction Disorders/physiopathology , Parkinson Disease/complications , Parkinson Disease/physiopathology , Predictive Value of Tests , REM Sleep Behavior Disorder/complications , REM Sleep Behavior Disorder/physiopathology , Sex Characteristics , Vision Disorders/diagnosis , Vision Disorders/etiology , Vision Disorders/physiopathologyABSTRACT
OBJECTIVE: Idiopathic REM sleep behavior disorder (RBD) is a potential preclinical marker for the development of neurodegenerative diseases, particularly Parkinson disease (PD) and Lewy body dementia. However, the long-term risk of developing neurodegeneration in patients with idiopathic RBD has not been established. Obtaining an accurate picture of this risk is essential for counseling patients and for development of potential neuroprotective therapies. METHODS: We conducted a follow-up study of all patients seen at the sleep disorders laboratory at the Hôpital du Sacré Coeur with a diagnosis of idiopathic RBD. Diagnoses of parkinsonism and dementia were defined according to standard criteria. Survival curves were constructed to estimate the 5-, 10-, and 12-year risk of developing neurodegenerative disease. RESULTS: Of 113 patients, 93 (82%) met inclusion criteria. The mean age of participants was 65.4 years and 75 patients (80.4%) were men. Over the follow-up period, 26/93 patients developed a neurodegenerative disorder. A total of 14 patients developed PD, 7 developed Lewy body dementia, 4 developed dementia that met clinical criteria for AD, and 1 developed multiple system atrophy. The estimated 5-year risk of neurodegenerative disease was 17.7%, the 10-year risk was 40.6%, and the 12-year risk was 52.4%. CONCLUSIONS: Although we have found a slightly lower risk than other reports, the risk of developing neurodegenerative disease in idiopathic REM sleep behavior disorder is substantial, with the majority of patients developing Parkinson disease and Lewy body dementia.
Subject(s)
Dementia/epidemiology , Neurodegenerative Diseases/epidemiology , Neurodegenerative Diseases/etiology , Parkinson Disease/epidemiology , REM Sleep Behavior Disorder/complications , REM Sleep Behavior Disorder/epidemiology , Aged , Female , Follow-Up Studies , Humans , Lewy Body Disease/epidemiology , Life Tables , Male , Middle Aged , Multiple System Atrophy/epidemiology , Neurodegenerative Diseases/psychology , Neuropsychological Tests , Polysomnography , Psychiatric Status Rating Scales , REM Sleep Behavior Disorder/psychology , Risk , Survival AnalysisABSTRACT
BACKGROUND: Rapid eye movement (REM) sleep behaviour disorder (RBD) is commonly associated with Parkinson's disease (PD), and recent studies have suggested that RBD in PD is associated with increased cognitive impairment, waking EEG slowing, autonomic impairment and lower quality of life on mental health components. However, it is unclear whether the association of RBD in PD has implications for motor manifestations of the disease. METHODS: The study evaluated 36 patients with PD for the presence of RBD by polysomnography. Patients underwent an extensive evaluation on and off medication by a movement disorders specialist blinded to the polysomnography results. Measures of disease severity, quantitative motor indices, motor subtypes, complications of therapy and response to therapy were assessed and compared using regression analysis that adjusted for disease duration and age. RESULTS: Patients with PD and RBD were less likely to be tremor predominant (14% vs 53%; p<0.02) and had a lower proportion of their Unified Parkinson Disease Rating Scale (UPDRS) score accounted for by tremor (8.2% vs 19.0%; p<0.01). An increased frequency of falls was noted among patients with RBD (38% vs 7%; p = 0.04). Patients with RBD demonstrated a lower amplitude response to their medication (UPDRS improvement 16.2% vs 34.8%; p = 0.049). Markers of overall disease severity, quantitative motor testing and motor complications did not differ between groups. CONCLUSIONS: The presence of altered motor subtypes in PD with RBD suggests that patients with PD and RBD may have a different underlying pattern of neurodegeneration than PD patients without RBD.
Subject(s)
Movement Disorders/epidemiology , Parkinson Disease/epidemiology , REM Sleep Behavior Disorder/epidemiology , Accidental Falls/statistics & numerical data , Aged , Electroencephalography , Female , Gait , Humans , Hypokinesia/diagnosis , Hypokinesia/epidemiology , Male , Movement Disorders/diagnosis , Muscle Rigidity/diagnosis , Muscle Rigidity/epidemiology , Parkinson Disease/diagnosis , Polysomnography , REM Sleep Behavior Disorder/diagnosis , Severity of Illness Index , Tremor/diagnosis , Tremor/epidemiologyABSTRACT
BACKGROUND: Idiopathic REM sleep behavior disorder (iRBD) might be a stage in the development of neurodegenerative disorders, especially Parkinson disease and dementia with Lewy bodies. Recent studies showing a slowing of waking EEG in iRBD suggest that iRBD is associated with cognitive impairment. OBJECTIVE: To compare patients with iRBD on measures of cognitive function and quantitative waking EEG. METHODS: Fourteen patients with iRBD and 14 healthy control subjects matched for age and educational level were studied. Subjects underwent an extensive neuropsychological evaluation and waking EEG recordings. RESULTS: Compared to controls, patients with iRBD showed a lower performance on neuropsychological tests measuring attention, executive functions, and verbal memory. Moreover, patients with iRBD showed EEG slowing (higher delta and theta power) during wakefulness in all brain areas compared to controls. However, no correlation was found between performance on cognitive tests and quantitative waking EEG in patients with iRBD. CONCLUSION: This study shows a co-occurrence of impaired cognitive profile and waking EEG slowing in patients with idiopathic REM sleep behavior disorder similar to that observed in early stages of some synucleinopathies.
Subject(s)
Brain/physiopathology , Cognition Disorders/diagnosis , Cognition Disorders/etiology , REM Sleep Behavior Disorder/complications , REM Sleep Behavior Disorder/psychology , Wakefulness , Aged , Cognition/physiology , Cognition Disorders/physiopathology , Decision Making/physiology , Electroencephalography , Humans , Lewy Body Disease/diagnosis , Lewy Body Disease/physiopathology , Lewy Body Disease/psychology , Male , Memory/physiology , Memory Disorders/diagnosis , Memory Disorders/etiology , Memory Disorders/physiopathology , Middle Aged , Neuropsychological Tests , Parkinson Disease/diagnosis , Parkinson Disease/physiopathology , Parkinson Disease/psychology , Predictive Value of Tests , Prognosis , REM Sleep Behavior Disorder/physiopathology , Reference Values , Sleep, REM/physiology , Wakefulness/physiologyABSTRACT
OBJECTIVE: To assess the relationship between the presence of REM sleep behavior disorder (RBD) and the cognitive profile of nondemented patients with Parkinson disease (PD). BACKGROUND: Cognitive impairment is an important nonmotor symptom in PD. Waking EEG slowing in nondemented PD has been related to the presence of RBD, a parasomnia affecting brainstem structures and frequently reported in PD. For this reason, RBD may be associated with cognitive impairment in PD. METHODS: Thirty-four patients with PD (18 patients with polysomnographic-confirmed RBD and 16 patients without RBD) and 25 healthy control subjects matched for age and educational level underwent sleep laboratory recordings and a comprehensive neuropsychological assessment. RESULTS: Patients with PD and concomitant RBD showed significantly poorer performance on standardized tests measuring episodic verbal memory, executive functions, as well as visuospatial and visuoperceptual processing compared to both patients with PD without RBD and control subjects. Patients with PD without RBD had no detectable cognitive impairment compared to controls. CONCLUSIONS: This study shows that cognitive impairment in nondemented patients with Parkinson disease (PD) is closely related to the presence of REM sleep behavior disorder, a sleep disturbance that was not controlled for in previous studies assessing cognitive deficits in PD.
Subject(s)
Brain/physiopathology , Cognition Disorders/etiology , Parkinson Disease/complications , REM Sleep Behavior Disorder/complications , Age Factors , Aged , Aging/physiology , Cognition Disorders/diagnosis , Cognition Disorders/psychology , Depressive Disorder/epidemiology , Disease Progression , Educational Status , Humans , Memory Disorders/diagnosis , Memory Disorders/etiology , Memory Disorders/psychology , Middle Aged , Neuropsychological Tests , Parkinson Disease/physiopathology , Parkinson Disease/psychology , Perceptual Disorders/diagnosis , Perceptual Disorders/etiology , Perceptual Disorders/psychology , Polysomnography , Predictive Value of Tests , Prognosis , REM Sleep Behavior Disorder/diagnosis , REM Sleep Behavior Disorder/psychology , Respiration Disorders/epidemiology , Sensitivity and SpecificityABSTRACT
Since the beginning of the 80s, Montréal's population of non French--and non English-speaking inhabitants has increased rapidly, especially in schools (estimates show that by the year 2000, this segment will represent about 50% of students). In addition, this population of diverse origins is composed of only a minority of Europeans; Caribbeans and Orientals make up the vast majority of immigrants that have settled in Montréal over the last decade. How does this unique mix of cultural backgrounds impact on the perception that these youth from multiethnic neighbourhoods have of their own culture and social relations? This is the basic issue that the authors have attempted to solve in the course of their research. The authors focused particularly on the identity-based tensions that stem from interaction between youth and the strategies they develop to overcome these tensions.